Jingwen Liu

Title: Innovations of Jingwen Liu in Lipid Reduction

Introduction

Jingwen Liu is a notable inventor based in Mountain View, CA (US). He has made significant contributions to the field of lipid reduction through his innovative research and patented technologies. With a total of 3 patents, Liu's work focuses on compounds and compositions that address various lipid-related health issues.

Latest Patents

Liu's latest patents include groundbreaking technologies aimed at reducing lipid levels. One of his patents describes compounds and compositions that provide prevention and treatment for hyperlipidemia, hypercholesterolemia, hypertriglyceridemia, hepatic steatosis, and metabolic syndrome. These compounds, derived from both natural and synthetic origins, are designed to lower total cholesterol, LDL-cholesterol, and triglycerides while increasing hepatic LDL receptor expression and activating AMP-activated protein kinase. Specific stereoisomers of compounds with lipid-lowering activity include 14R-(+)-corypalmine, 14R,13S-(+)-corydaline, 14R-(+)-tetrahydropalmatin, (+)-corlumidin, d-(+)-bicuculline, and (+)-egenine. Another patent focuses on methods of making and using compounds that also target lipid levels, emphasizing their role in preventing and treating various metabolic disorders.

Career Highlights

Jingwen Liu is currently associated with Cvi Pharmaceuticals Limited, where he continues to advance his research in lipid reduction. His work has garnered attention for its potential impact on public health, particularly in addressing conditions related to high lipid levels.

Collaborations

Liu collaborates with esteemed colleagues such as Haiyan Liu and Junbo Wang, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Jingwen Liu's contributions to the field of lipid reduction through his patents and research are noteworthy. His innovative approaches have the potential to significantly improve health outcomes related to lipid levels.